<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T05:19:36Z</responseDate>
  <request identifier="oai:figshare.com:article/33770956" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33770956</identifier>
        <datestamp>2026-09-15T04:28:10Z</datestamp>
        <setSpec>category_16</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Data Sheet 1_Explainable random forest–SHAP framework for Montreal phenotype–stratified prediction of one-year complications in Crohn’s disease.pdf</dc:title>
          <dc:creator>Kun Xia (9853)</dc:creator>
          <dc:creator>Ying Shi (115282)</dc:creator>
          <dc:creator>Xiaohan Huang (790985)</dc:creator>
          <dc:creator>Yuwei Zhang (388956)</dc:creator>
          <dc:creator>Liwei Suo (24912130)</dc:creator>
          <dc:creator>Shuntian Cai (11438998)</dc:creator>
          <dc:creator>Lingfeng Zhong (11659945)</dc:creator>
          <dc:creator>Dayi Zheng (24912133)</dc:creator>
          <dc:creator>Mengjie Lin (5771705)</dc:creator>
          <dc:creator>Sirui Wan (16233953)</dc:creator>
          <dc:creator>Linwei Wang (6297932)</dc:creator>
          <dc:creator>Jianlin Ren (482527)</dc:creator>
          <dc:creator>Qingan Xia (24912136)</dc:creator>
          <dc:creator>Hongzhi Xu (302803)</dc:creator>
          <dc:creator>Yanyun Fan (6741764)</dc:creator>
          <dc:subject>Physiology</dc:subject>
          <dc:subject>artificial intelligence</dc:subject>
          <dc:subject>Crohn’ s disease</dc:subject>
          <dc:subject>inflammatory bowel disease</dc:subject>
          <dc:subject>machine learning</dc:subject>
          <dc:subject>prognosis factors</dc:subject>
          <dc:description>Background&lt;p&gt;Early identification of phenotype-stratified, short-term complication risk remains a critical unmet need in Crohn’s disease (CD). Existing models focus on single outcomes and lack interpretability, limiting clinical use. We developed a clinically interpretable machine-learning framework to enable Montreal phenotype–stratified prediction of three one-year complication categories: bowel resection (Task 1), perianal complications (Task 2), and abdominal complications (Task 3).&lt;/p&gt;Methods&lt;p&gt;Data from 370 patients across two clinical centers were pooled for model development and evaluated using stratified 10-fold cross-validation. Within each fold, data preprocessing, LASSO feature selection, SMOTE-Tomek resampling, model optimization, calibration, and threshold determination were restricted to the training data. Seven machine-learning algorithms were compared in terms of discrimination, calibration, with decision-curve analysis used to explore potential net benefit. SHapley Additive exPlanations (SHAP) were used for model interpretation, and nomograms, heatmaps, and a web-based calculator were generated as exploratory visualizations of model-derived risk estimates rather than as clinical decision-support tools. Phenotype-stratified and non-linear associations between CDAI and complication risk were further analyzed within the Montreal framework.&lt;/p&gt;Results&lt;p&gt;Within one year after discharge, bowel resection, perianal complications, and abdominal complications occurred in 70 (18.9%), 142 (38.4%), and 84 (22.7%) patients, respectively. Random Forest showed the most consistent overall performance, achieving an AUROC of 0.86 (95% CI, 0.82–0.90) for bowel resection, 0.71 (95% CI, 0.64–0.78) for perianal complications, and 0.73 (95% CI, 0.69–0.78) for abdominal complications. SHAP identified distinct predictors across outcomes: disease behavior, nutritional support therapy, and disease duration for bowel resection; prior perianal complications, extraintestinal manifestations, and CDAI for perianal complications; and prior abdominal complications, nutritional support therapy, and Montreal L3 phenotype for abdominal complications. Receipt of NST was interpreted as a clinical marker of nutritional depletion and greater disease burden rather than as a causal risk factor. Montreal-based stratification revealed marked heterogeneity, with isolated small-bowel disease associated with higher risks of bowel resection and abdominal complications, and isolated colonic disease with the highest burden of perianal complications.&lt;/p&gt;Conclusion&lt;p&gt;The interpretable RF–SHAP framework showed potential for Montreal phenotype–stratified prediction of one-year complication risk in CD and inform future evaluation of risk stratification and phenotype-informed management.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-15T04:28:10Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fphys.2026.1902465.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Data_Sheet_1_Explainable_random_forest_SHAP_framework_for_Montreal_phenotype_stratified_prediction_of_one-year_complications_in_Crohn_s_disease_pdf/33770956</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
